Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TID Lovenox Dosing in Pregnancy
NCT04861103Phase 4Recruiting
- Sponsor
- University of California, Irvine
- Start
- Oct 2020
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University of California, Irvine. Started Oct 2020; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04861103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04861103.